Tu1617: CARVEDILOL IS ASSOCIATED WITH IMPROVED MAJOR ADVERSE LIVER-RELATED OUTCOMES COMPARED TO OTHER NON-SELECTIVE BETABLOCKERS IN COMPENSATED CIRRHOSIS
0Citations signalées
0Institutions associées
0Pays d’affiliation
Résumé indisponible dans les métadonnées reçues.
Sujets associés
Liver Disease Diagnosis and TreatmentLiver Disease and TransplantationHepatitis C virus research